Table 1.
Variables measured and available in the dataset.
| Name | Description | Values | Significance |
|---|---|---|---|
| Type | Type of sample | 1/2/3 | NMIBC/MIBC/control |
| Age | Diagnosis age | Numeric | Years |
| N History | Identification number | Numeric | — |
| Gender | Gender | 1/2 | Male/female |
| Fdiagn | Diagnostic data | Date | DD/MM/YYYY |
| Tobacco | Tobacco smoking | 0/1 | No/yes |
| Alcohol | Alcohol consumption | 0/1 | No/yes |
| Af | Family history of BC | 0/1 | No/yes |
| Mfum | More than 20 cigarettes a day | 0/1 | No/yes |
| Otrosf | Other risk factors of BC | Text | Not analyzable |
| Hematuri | Haematuria | 0/1 | No/yes |
| Irritat | Irritative syndrome | 0/1 | No/yes |
| Dolorsup | Suprapubic pain | 0/1 | No/yes |
| Otros | Other symptoms | 0/1 | No/yes |
| Diagn | Diagnostic type | 1/2 | Symptomatic/incidental |
| Tumor | Number of tumors | Numeric | Numeric |
| Creat | Creatinine | Numeric | mg/dL |
| Got | GOT | Numeric | U/L |
| Gpt | GPT | Numeric | U/L |
| Hem | Number of red blood cells | Numeric | E6/uL |
| Hb | Haemoglobin | Numeric | g/dL |
| Hcto | Hematocrit | Numeric | % |
| Ca | Calcium | Numeric | mg/dL |
| P | Phosphorum | Numeric | mg/dL |
| Falc | Alcaline phosphatase | Numeric | U/L |
| Citesp, Citarr; eco, UIV; CT, cistosc | Diagnosis test performed | Text | Not analyzable |
| Multiple | Multiplicity | 1/2 | Single/multiple |
| Tam | Size (cm) | numeric | cm |
| TAM3CM | Size ≥3 cm | 1/2 | No/yes |
| Aspect | Endoscopic aspect | 1/2/3 | 1 Superficial/2 infiltrative/3 intermediate |
| ASPESUP | Superficial aspect | 1/2 | Yes/no |
| Tto | Type of adjuvant therapy | Text | Not analyzable |
| ADYUV | Adjuvant therapy | 1/2 | Yes/no |
| Jewett | Histologic staging | 1/2/3 | A/B/C-D |
| G | Grade | 1/2/3 | G1/G2/G3 |
| G23 | Grades 2 or 3 | 1/2 | No/yes |
| Tnm | TNM | 1/2 | Ta/T1 |
| Gries | EORTC risk group | 1/2 | Low-intermediate/high |
| Grx | Millan risk group | 1/2 | Low-intermediate/high |
| AP, tipoAP | Type of BC | 1/2/9 | Not analyzable TCC/SC/other |
| p53iha | P53 immunohistochemistry | 1/2/3 | +/++/+++ |
| p53ria | P53 quantified | Numeric | ng/ml |
| Neu | Prot p185 quantified | Numeric | HNU (0.05 fmol/mg)/ml |
| p16 | Prot p16 immunohistochemistry | 1/2/3 | +/++/+++ |
| Recid | Relapse | 1/2 | Yes/no |
| Fechare | First relapse data | Date | DD/MM/YYYY |
| narecid | Number of relapses | Numeric | Number |
| narecidp | Number of relapses till progression | Numeric | Number |
| Prog | Progression | 1/2 | Yes/no |
| Fprog | Progression date | Date | DD/MM/YYYY |
| Metas | Metastatic disease | 1/2 | Yes/no |
| Muerte | Death | 1/2 | Yes/no |
| Fechmuerte | Date of death | Date | DD/MM/YYYY |
| Mporca | Cancer specific mortality | 1/2 | Yes/no |
| Recm | Number of relapses till death | Numeric | Number |
| fechaultre | Last Revision Date | Date | DD/MM/YYYY |
| Egfr | EGFR quantified | Numeric | EGFR fmol/protein mg |
| Logneu | Neu logarithm | Numeric | Number of months |
| Super | Survival (months) | Numeric | Number of months |
| Ile | Relapse-free survival | Months | Number of months |
| Tprogre | Progression-free survival | Months | Number of months |
| Tmetas | Metastatic disease-free survival | Months | Number of months |
| Np53ria | p53 RIATertile | 1/2/3 | Tertile 1/tertile 2/tertile 3 |
| Nneu | NeuTertile | 1/2/3 | Tertile 1/tertile 2/tertile 3 |
| Negfr | EGFRTertile | 1/2/3 | Tertile 1/tertile 2/tertile 3 |
| Filtro | NMIBC | ||
| edad70 | Older than 70 years | 1/2 | Yes/no |